Obesity Clinical Trials in Chicago

Showing 241-242 of 242 trials

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

NCT00449202

The purpose of this study is to evaluate the safety, preliminary efficacy, and pharmacokinetics of two 14-day cycles of escalating oral doses of MP 101 in 100 obese adult subjects.

Obesity

Manhattan Pharmaceuticals100 participantsStarted Jun 2006

Baton Rouge, Louisiana, United States • Salt Lake City, Utah, United States • Basel, Switzerland

UNKNOWNPhase 2/3849 miles

Glaser Obesity Study

NCT00209482

This study will determine if the drug metformin, coupled with diet and exercise counseling, will help obese adolescents lose weight.

Obesity

Glaser Pediatric Research Network76 participantsStarted Oct 2003

Los Angeles, California, United States • San Francisco, California, United States • Stanford, California, United States +2 more locations

PreviousPage 13 of 13

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Glaser Obesity Study

Obesity Trials in Other Cities

Other Conditions in Chicago